Hemostasis Today

March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Alireza Pishgahi on Attenuation of Memory Impairment After Ischemia
Dec 3, 2025, 07:42

Alireza Pishgahi on Attenuation of Memory Impairment After Ischemia

Alireza Pishgahi, President at Novagena, shared on LinkedIn:

”I am proud to announce that our valuable study on Stroke Regeneration have been published.

Looking forward to bring it from bench to bedside.”

Stroke is the second leading cause of death globally, placing a heavy burden on both public health and economies.

This study explored the impact of autologous conditioned serum (ACS) on memory and related molecular factors in a mouse model of ischemic stroke.

The findings suggest that intranasal ACS treatment after stroke improves memory, likely by elevating IGF-1 levels, reducing inflammation via IL-1β inhibition, and regulating tau protein levels.

Read the full article here.

Article: Intranasal Autologous Conditioned Serum Attenuates Memory Impairment After mPFC Ischemia in Mice

Authors: Sareh Kazmi, Neda Yazdanfar, Fatemehsadat Seyedaghamiri, Alireza Pishgahi, Mehdi Yousefi, Tahereh Ghadiri, Saeed Sadigh-Eteghad, Mehdi Farhoudi

Alireza Pishgahi on Attenuation of Memory Impairment After Ischemia

Stay updated on all scientific advances with Hemostasis Today.